TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
The Single Biggest Threat to the Canadian Cannabis Oligarchy
Investing
B.C. Releases its Initial Plan for How Pot Will Be Sold in the Province
Investing
Canopy Growth Corp.: Buy Now or Wait for a Lower Price?
Investing
Is Aphria Inc. a Must-Buy After Sealing a Deal With Shoppers Drug Mart?
Investing
Cannabis Investors: Could Public Pressure Delay Legalization?
Investing
Despite Heightened Valuations, This Cannabis Company May Have More Room to Run
Investing
Is Canopy Growth Corp. Stock a Buy After a 17% Plunge From the Peak?
Investing
This Non-Cannabis Stock Could Get a Big Boost From Marijuana Legalization
Investing
Better Marijuana Stock for 2018: Canopy Growth Corp. or Aurora Cannabis Inc.?
Top TSX Stocks
Top Stocks for December
Investing
Cannabis Investors: This Pot Stock Might Be a Better Buy Than Canopy Growth Corp.